Pharmacologic mydriasis in an infant following parental use of topical glycopyrronium tosylate. J AAPOS 2019 Dec;23(6):359-361
Date
11/05/2019Pubmed ID
31683011DOI
10.1016/j.jaapos.2019.09.012Scopus ID
2-s2.0-85075446609 (requires institutional sign-in at Scopus site) 3 CitationsAbstract
We report the case of a 2-month-old boy with unilateral pharmacologic mydriasis from inadvertent exposure to glycopyrronium after parental use of glycopyrronium wipes. Clinician familiarity with the potential effects of glycopyrronium exposure may aid in the recognition, diagnosis, and prevention of pharmacologic mydriasis as well as the reduction of costly and unnecessary evaluations.
Author List
Seto S, Teo AA, Walsh RDAuthor
Ryan Walsh MD Associate Professor in the Ophthalmology and Visual Sciences department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Administration, TopicalCholinergic Antagonists
Glycopyrrolate
Humans
Infant
Male
Mydriasis
Parents
Pupil